These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 25919636)

  • 1. Plasma Sclerostin in HIV-Infected Adults on Effective Antiretroviral Therapy.
    Erlandson KM; O'Riordan M; Hileman CO; Rapaport E; Labbato D; Campbell TB; McComsey GA
    AIDS Res Hum Retroviruses; 2015 Jul; 31(7):731-8. PubMed ID: 25919636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statin therapy decreases N-terminal pro-B-type natriuretic peptide in HIV: randomized placebo-controlled trial.
    Dirajlal-Fargo S; Kinley B; Jiang Y; Longenecker CT; Hileman CO; Debanne S; McComsey GA
    AIDS; 2015 Jan; 29(3):313-21. PubMed ID: 25686680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationships between inflammation, immune activation, and bone health among HIV-infected adults on stable antiretroviral therapy.
    Erlandson KM; OʼRiordan M; Labbato D; McComsey GA
    J Acquir Immune Defic Syndr; 2014 Mar; 65(3):290-8. PubMed ID: 24525466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rosuvastatin treatment reduces markers of monocyte activation in HIV-infected subjects on antiretroviral therapy.
    Funderburg NT; Jiang Y; Debanne SM; Storer N; Labbato D; Clagett B; Robinson J; Lederman MM; McComsey GA
    Clin Infect Dis; 2014 Feb; 58(4):588-95. PubMed ID: 24253250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in bone turnover markers with HIV seroconversion and ART initiation.
    Slama L; Reddy S; Phair J; Palella FJ; Brown TT;
    J Antimicrob Chemother; 2017 May; 72(5):1456-1461. PubMed ID: 28175307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between inhibitors of the Wnt signalling pathway (sclerostin and Dickkopf-1) and carotid intima-media thickness in postmenopausal women with type 2 diabetes mellitus.
    Gaudio A; Privitera F; Pulvirenti I; Canzonieri E; Rapisarda R; Fiore CE
    Diab Vasc Dis Res; 2014 Jan; 11(1):48-52. PubMed ID: 24227537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sclerostin and DKK-1: two important regulators of bone metabolism in HIV-infected youths.
    Mora S; Puzzovio M; Giacomet V; Fabiano V; Maruca K; Capelli S; Nannini P; Lombardi G; Zuccotti GV
    Endocrine; 2015 Aug; 49(3):783-90. PubMed ID: 25596857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Markers of inflammation and CD8 T-cell activation, but not monocyte activation, are associated with subclinical carotid artery disease in HIV-infected individuals.
    Longenecker CT; Funderburg NT; Jiang Y; Debanne S; Storer N; Labbato DE; Lederman MM; McComsey GA
    HIV Med; 2013 Jul; 14(6):385-90. PubMed ID: 23332012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sclerostin is positively associated with bone mineral density in men and women and negatively associated with carotid calcified atherosclerotic plaque in men from the African American-Diabetes Heart Study.
    Register TC; Hruska KA; Divers J; Bowden DW; Palmer ND; Carr JJ; Wagenknecht LE; Hightower RC; Xu J; Smith SC; Dietzen DJ; Langefeld CD; Freedman BI
    J Clin Endocrinol Metab; 2014 Jan; 99(1):315-21. PubMed ID: 24178795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with serum soluble inhibitors of Wnt-β-catenin signaling (sclerostin and dickkopf-1) in patients undergoing peritoneal dialysis.
    Yamada S; Tsuruya K; Tokumoto M; Yoshida H; Ooboshi H; Kitazono T
    Nephrology (Carlton); 2015 Sep; 20(9):639-45. PubMed ID: 25974190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Switching from tenofovir to abacavir in HIV-1-infected patients with low bone mineral density: changes in bone turnover markers and circulating sclerostin levels.
    Negredo E; Diez-Pérez A; Bonjoch A; Domingo P; Pérez-Álvarez N; Gutierrez M; Mateo G; Puig J; Echeverría P; Escrig R; Clotet B
    J Antimicrob Chemother; 2015 Jul; 70(7):2104-7. PubMed ID: 25769303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sclerostin levels associated with inhibition of the Wnt/β-catenin signaling and reduced bone turnover in type 2 diabetes mellitus.
    Gaudio A; Privitera F; Battaglia K; Torrisi V; Sidoti MH; Pulvirenti I; Canzonieri E; Tringali G; Fiore CE
    J Clin Endocrinol Metab; 2012 Oct; 97(10):3744-50. PubMed ID: 22855334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma IL-6 levels are independently associated with atherosclerosis and mortality in HIV-infected individuals on suppressive antiretroviral therapy.
    Hsu DC; Ma YF; Hur S; Li D; Rupert A; Scherzer R; Kalapus SC; Deeks S; Sereti I; Hsue PY
    AIDS; 2016 Aug; 30(13):2065-74. PubMed ID: 27177313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sclerostin distribution in children and adolescents with type 1 diabetes mellitus and correlation with bone metabolism and bone mineral density.
    Tsentidis C; Gourgiotis D; Kossiva L; Marmarinos A; Doulgeraki A; Karavanaki K
    Pediatr Diabetes; 2016 Jun; 17(4):289-99. PubMed ID: 26094958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse bone health and abnormal bone turnover among perinatally HIV-infected Asian adolescents with virological suppression.
    Sudjaritruk T; Bunupuradah T; Aurpibul L; Kosalaraksa P; Kurniati N; Prasitsuebsai W; Sophonphan J; Sohn AH; Ananworanich J; Puthanakit T;
    HIV Med; 2017 Apr; 18(4):235-244. PubMed ID: 27477214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating sclerostin and dickkopf-1 levels in ossification of the posterior longitudinal ligament of the spine.
    Kashii M; Matuso Y; Sugiura T; Fujimori T; Nagamoto Y; Makino T; Kaito T; Ebina K; Iwasaki M; Yoshikawa H
    J Bone Miner Metab; 2016 May; 34(3):315-24. PubMed ID: 26040409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statin Therapy Does Not Reduce Liver Fat Scores in Patients Receiving Antiretroviral Therapy for HIV Infection.
    El Kamari V; Hileman CO; Gholam PM; Kulkarni M; Funderburg N; McComsey GA
    Clin Gastroenterol Hepatol; 2019 Feb; 17(3):536-542.e1. PubMed ID: 29908359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tenofovir disoproxil fumarate and an optimized background regimen of antiretroviral agents as salvage therapy: impact on bone mineral density in HIV-infected children.
    Gafni RI; Hazra R; Reynolds JC; Maldarelli F; Tullio AN; DeCarlo E; Worrell CJ; Flaherty JF; Yale K; Kearney BP; Zeichner SL
    Pediatrics; 2006 Sep; 118(3):e711-8. PubMed ID: 16923923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High circulating sclerostin is present in patients with thalassemia-associated osteoporosis and correlates with bone mineral density.
    Voskaridou E; Christoulas D; Plata E; Bratengeier C; Anastasilakis AD; Komninaka V; Kaliontzi D; Gkotzamanidou M; Polyzos SA; Dimopoulou M; Terpos E
    Horm Metab Res; 2012 Nov; 44(12):909-13. PubMed ID: 22581647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating sclerostin in disorders of parathyroid gland function.
    Costa AG; Cremers S; Rubin MR; McMahon DJ; Sliney J; Lazaretti-Castro M; Silverberg SJ; Bilezikian JP
    J Clin Endocrinol Metab; 2011 Dec; 96(12):3804-10. PubMed ID: 21937621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.